Abstract
In this issue of Blood, Poe et al identify the pathogenic and druggable B-cell receptor (BCR)–Notch axis as a feed-forward loop in patients with chronic graft-versus-host disease (cGVHD), providing a rationale and methods for its therapeutic targeting.1
Original language | English (US) |
---|---|
Pages (from-to) | 2053-2054 |
Number of pages | 2 |
Journal | Blood |
Volume | 130 |
Issue number | 19 |
DOIs |
|
State | Published - Nov 9 2017 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology